CAR T-cell therapy was named by the American Society of Clinical Oncology as the 2018 Advance of the Year. CAR T-cell therapy is a type of immunotherapy called “adoptive cell immunotherapy.” This type of immunotherapy allows doctors to genetically reprogram patients’ own immune cells to find and attack cancer cells throughout the body. This video describes CAR T-cell therapy, including what it is and how it works.
More Information
CAR T-Cell Immunotherapy: The 2018 Advance of the Year: [ Ссылка ]
Understanding Immunotherapy: [ Ссылка ]
Side Effects of Immunotherapy: [ Ссылка ]
Immunotherapy 2.0: The 2017 Clinical Cancer Advance of the Year: [ Ссылка ]
Immunotherapy: The 2016 Clinical Cancer Advance of the Year: [ Ссылка ]
